1Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self- tolerance maintained by activated T cells expressing IL - 2 receptor alpha - chains (CD25). Breakdown of a single mechanism of self - tolerance causes various autoimmune diseases[J]. J Immunol, 1995,155(3) :1 151-1 164.
2Brunkow ME,Jeffery EW,Hjerrild KA,et al. Disruption of a new forkhead/winged - helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [J]. Nat Genet, 2001,27( 1 ) :68-73.
3Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 [ J ]. Nat Immunol, 2005, 6(4) :331-337.
4Aarts - Riemens T, Emmelot ME, Verdonck LF, et al. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4 ( +)CD25(-) cells[J]. EurJ Immunol,2008,38(5): 1 381-1 390.
5Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells[J]. Nat Immunol, 2003,4(4) :330-336.
6Hori S, Nomura T, Sakaguehi S. Control of regulatory T cell development by the transcription factor Foxp3[ J]. Science, 2003, 299(5609):1 057-1 061.
7i Li B, Greene MI. FOXP3 actively represses transcription by recruiting the HAT/HDAC complex [ J]. Cell Cycle, 2007,6(12) :1 432-1 436.
8Ono M, Yaguchi H, Ohkura N, et al. Foxp3 controls regulatory T - cell function by interacting with AML1/Runxl [J ]. Nature, 2007, 446 (7136 ) :685-689.
9Wu Y, Borde M, Heissmeyer V, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT [J]. Cell, 2006,126(2) :375-387.
10Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF - kappa B to repress cytokine gene expression and effector functions of T helper cells [ J]. Proe Natl Acad Sei USA, 2005, 102 (14) :5 138-5 143.
同被引文献11
1Libby P, Ridker PM, Hansson GK, et al. Inflammation in atherosclemsis: frompathophy-siology to practice [ J ]. J Am Coll Cardiol, 2009,54(23) :2129-2138.
2Galkina E, Ley K. Immune and inflammatory mechanisms of athero- sclerosis [ J ]. Annu Rev Immu nol, 2009,27 ( 1 ) : 165 - 197.
3Woollard KJ,Geissmann F. Monocytes in atherosclerosis: subsets and functions [ J ]. Nat Rev Cardiol,2010,7 ( 2 ) :77-86.
5Cheng X, Yu X, Ding Y J, et al. The Th17/Treg imbalance in patients with acute coronary syndrome [J]. Clin Immunol, 2008,127 ( 1 ) : 89- 97.
6Li Q, Wang Y, Chen K, et al. The role of oxidized low-density lipopro- rein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome [J]. Biochem Biophys Res Commun, 2010,394 ( 3 ) : 836-842.
7Kofler S,Schlichting C,Jankl S, et al. Dualmode of HMG-CoA reductase inhibition on dendritic cell invasion [ J ]. Atherosclerosis, 2008, 197(1) :105-110.
